February 5, 2010 โ A new, large-scale pivotal phase III trial has been initiated for edoxaban to evaluate its ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
January 22, 2010 - A new study by the University of Michigan Medical School and VA Ann Arbor Health System ...
Primarily used in the hospital setting, NATRECOR (nesiritide) is used intravenously in patients who have acutely ...
January 21, 2010 - A recent study found generic epoprostenol is a safe and effective therapy alternative to brand ...
January 11, 2010 โ A hypertension drug using a combination of telmisartan/amlodipine, which requires less ...
January 11, 2010 โ The first patients were enrolled in the phase 3 clinical trials for a drug designed to lower ...
January 7, 2010 โ Doctors with Virginia Interventional and Vascular Associates (VIVA) report success in treating ...
January 7, 2010 โ Anti-platelet treat with Effient (prasugrel) compared with Plavix (clopidogrel) was more cost ...
January 4, 2010 โ The first patient was enrolled the TAXUS Liberte arm of the Dual Anti-Platelet Therapy (DAPT) ...
December 30, 2009 โ Medical device company Emerging Healthcare Solutions LLC (EHS) entered into an agreement to ...
December 24, 2009 โ A clinical reference and pharmaceutical database application was released this week for the ...
December 23, 2009 โ An investigational beta-blocker drug may be tested to see if it helps slow the progression of ...
December 23, 2009 โ The Cleveland Clinic this week initiated a phase II trial examining a new oral therapy for ...
December 22, 2009 โ A drug manufacturer recently filed paperwork with the FDA to produce a generic version of the ...
December 21, 2009 โ Revised guidelines on the use of beta-blockers for noncardiac surgery say therapy should ...